DK670988A - Anvendelse af dl-5((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)-thiazolidin-2,4-dion til fremstilling af et farmaceutisk praeparat til saenkning af serumchlolesterolniveauer - Google Patents

Anvendelse af dl-5((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)-thiazolidin-2,4-dion til fremstilling af et farmaceutisk praeparat til saenkning af serumchlolesterolniveauer

Info

Publication number
DK670988A
DK670988A DK670988A DK670988A DK670988A DK 670988 A DK670988 A DK 670988A DK 670988 A DK670988 A DK 670988A DK 670988 A DK670988 A DK 670988A DK 670988 A DK670988 A DK 670988A
Authority
DK
Denmark
Prior art keywords
thiazolidine
preparation
dihydro
benzyl
methyl
Prior art date
Application number
DK670988A
Other languages
English (en)
Other versions
DK670988D0 (da
Inventor
Michael Norman Krupp
Archie Calhoun Swindell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK670988D0 publication Critical patent/DK670988D0/da
Publication of DK670988A publication Critical patent/DK670988A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK670988A 1987-12-02 1988-12-01 Anvendelse af dl-5((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)-thiazolidin-2,4-dion til fremstilling af et farmaceutisk praeparat til saenkning af serumchlolesterolniveauer DK670988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/127,858 US4798835A (en) 1987-12-02 1987-12-02 dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent

Publications (2)

Publication Number Publication Date
DK670988D0 DK670988D0 (da) 1988-12-01
DK670988A true DK670988A (da) 1989-07-24

Family

ID=22432331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK670988A DK670988A (da) 1987-12-02 1988-12-01 Anvendelse af dl-5((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)-thiazolidin-2,4-dion til fremstilling af et farmaceutisk praeparat til saenkning af serumchlolesterolniveauer

Country Status (16)

Country Link
US (1) US4798835A (da)
EP (1) EP0319288B1 (da)
JP (1) JPH01186883A (da)
KR (1) KR900006993B1 (da)
AT (1) ATE81456T1 (da)
AU (1) AU604176B2 (da)
CA (1) CA1313139C (da)
DE (1) DE3875324T2 (da)
DK (1) DK670988A (da)
HU (1) HU204433B (da)
IE (1) IE883600L (da)
IL (1) IL88513A (da)
MY (1) MY103498A (da)
PH (1) PH24873A (da)
PT (1) PT89123B (da)
ZA (1) ZA888968B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
EP0494405B2 (en) * 1991-01-10 2000-04-19 Transcend Therapeutics, Inc. Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物

Also Published As

Publication number Publication date
IL88513A0 (en) 1989-06-30
AU2647188A (en) 1989-06-08
EP0319288B1 (en) 1992-10-14
DK670988D0 (da) 1988-12-01
HUT54045A (en) 1991-01-28
PT89123A (pt) 1989-12-29
CA1313139C (en) 1993-01-26
ATE81456T1 (de) 1992-10-15
AU604176B2 (en) 1990-12-06
HU204433B (en) 1992-01-28
IE883600L (en) 1989-06-02
EP0319288A3 (en) 1990-12-27
JPH0460582B2 (da) 1992-09-28
DE3875324T2 (de) 1993-02-25
EP0319288A2 (en) 1989-06-07
MY103498A (en) 1993-06-30
KR890009922A (ko) 1989-08-04
JPH01186883A (ja) 1989-07-26
ZA888968B (en) 1990-07-25
PT89123B (pt) 1993-09-30
KR900006993B1 (ko) 1990-09-25
DE3875324D1 (de) 1992-11-19
IL88513A (en) 1994-04-12
PH24873A (en) 1990-12-26
US4798835A (en) 1989-01-17

Similar Documents

Publication Publication Date Title
DK215887D0 (da) Farmaceutisk praeparat af omeprazol til oral ind- gift
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK217188D0 (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK0564505T3 (da) Administrationsform til mikroblæreekkokontrastmidler
DK447489A (da) Metode til stabilisering af blod
DK184890A (da) Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme
DK670988D0 (da) Anvendelse af dl-5((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)-thiazolidin-2,4-dion til fremstilling af et farmaceutisk praeparat til saenkning af serumchlolesterolniveauer
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
DK313688A (da) Anvendelse af doxazosin til fremstilling af farmaceutiske praeparater mod atherosclerose
NO167285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nafto(1,2-b)-1,4-tiazepinon-derivater.
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
NO905364D0 (no) Fremgangsmaate ved fremstilling av alkansyrederivater.
DE3782594D1 (de) Arzneimittel zur transdermalen verabreichung von nicorandil.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
DK500589A (da) Farmaceutisk praeparat til behandling af lungeobstruktioner
DK441987A (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK80087A (da) Farmaceutisk praeparat til parenteral indgift
IT8719426A0 (it) Preparazione di amoxicillina iniettabile famraceutica.
NO166789C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv kalsium-10-propyl-2,8-bis(1h-tetrazol-5-yl)-4h, 6h-benzo(1,2-b;5,4-b')di-pyran-4,6-dion.
NO169713C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-arylkarbonyl-1-((4-morfolinyl)alkyl)-1h-indoler.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment